DRUG
BRIGHT MINDS BIOSCIENCES INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
BRIGHT MINDS BIOSCIENCES INC (DRUG) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$32.92M; the largest are Steven Cohen, Izzy Englander, Ken Griffin. This quarter: 3 new, 1 added. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Common-stock holders4
Congress trades0
Price$49.74vs quarter-end-29.15%
Sectors0
This quarter's moves
Top holderNew3
Added1
Trimmed / sold0
Steven CohenCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.